MedPath
TGA Approval

BRIVIACT brivaracetam 50mg/5mL injection vial (243795)

243795

BRIVIACT brivaracetam 50mg/5mL injection vial

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

August 4, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/d9e7fb5d206625c5f0ec3d78923d319d.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/e92f971dcb54a0d63b022065de8060a1.pdf

Active Ingredients

brivaracetam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BRIVIACT brivaracetam 50mg/5mL injection vial (243795) - TGA 批准文号 | MedPath